- Soliciting investigator-initiated research proposals focused on the broad area of injectable orthobiologics for the treatment of knee osteoarthritis, including but not limited to the following areas:
- Determining clinical efficacy and safety of an injectable orthobiologic treatment(s) to provide decreased pain and improved function, preferably through the assessment of a balanced outcome scorecard measuring patient-reported outcomes and appropriate clinical outcomes.
- Assessing the mechanisms of action of an injectable orthobiologic treatment(s) in knee osteoarthritis to reduce pain and improve function or modify the progression of disease in patients with knee osteoarthritis.
Areas of research focus may include translational preclinical or clinical research to preferably include pilot human studies.
Deadline: Feb. 21, 2023